bovin
ephemer
fever
bef
caus
bovin
ephemer
fever
viru
befv
also
known
day
fever
acut
febril
infect
cattl
water
buffalo
typic
clinic
symptom
bef
character
rapid
onset
rapid
recoveri
clinic
sign
fever
depress
muscl
stiff
oral
nasal
discharg
joint
pain
lamen
diseas
frequent
distribut
vast
expans
world
includ
tropic
subtrop
temper
region
africa
middl
east
australia
asia
lead
seriou
econom
loss
cattl
industri
loss
milk
product
signific
impact
trade
date
specif
treatment
drug
avail
befv
befv
belong
genu
ephemeroviru
famili
rhabdovirida
consist
singl
strand
negativesens
rna
genom
lipid
envelop
five
structur
protein
g
protein
play
import
role
induc
neutral
antibodi
also
close
associ
cell
tropism
pathogen
fusion
interact
host
cellular
receptor
protein
g
consist
five
major
neutralis
site
defin
befv
g
protein
specif
monoclon
antibodi
mab
competit
elisa
among
site
site
compos
two
minim
b
cell
epitop
linear
neutralis
site
involv
elicit
neutral
antibodi
report
site
predict
face
viral
membran
prefus
postfus
form
trimer
may
approach
antibodi
therefor
protein
use
potenti
target
antivir
drug
screen
phage
display
wellestablish
power
popular
technolog
extens
use
mani
field
includ
antibodi
engin
ligand
screen
peptid
drug
discoveri
manufactur
diseas
molecular
diagnost
analysi
biosens
vaccin
research
develop
high
capac
abund
random
phage
display
librari
make
appropri
highthroughput
screen
peptid
ligand
specif
bind
given
target
virolog
sever
peptid
identifi
potenti
antivir
classic
swine
fever
viru
transmiss
gastroenter
viru
influenza
viru
newcastl
diseas
viru
human
immunodefici
viru
hiv
hepat
b
viru
use
phage
display
technolog
howev
report
screen
polypeptid
bind
befv
phage
display
librari
studi
identifi
specif
peptid
capabl
bind
protein
befv
phage
display
librari
use
immobil
befv
protein
target
analyz
role
context
befv
infect
vitro
great
signific
potenti
diagnosi
treatment
bef
phagedisplay
peptid
librari
purchas
new
england
biolab
ipswich
usa
titer
peptid
librari
plaqu
form
unit
pfuml
contain
independ
random
peptid
sequenc
befv
isol
store
rumin
diseas
research
center
shandong
normal
univers
jinan
shandong
provinc
china
tissu
cultur
infect
dose
befv
determin
reedmuench
method
antibefv
antibodi
extract
cattl
preserv
laboratori
concret
clinic
serum
sampl
collect
detect
dairi
cattl
case
befv
infect
china
antibodi
befv
identifi
microneutr
assay
accord
instruct
agricultur
industri
criteria
peopl
republ
china
public
antibefv
antibodi
studi
appli
analyz
bioactiv
purifi
recombin
protein
western
blot
cell
incub
dulbecco
modifi
eagl
medium
dmem
invitrogen
carlsbad
ca
usa
supplement
fetal
bovin
serum
fb
gibco
usa
prokaryot
express
vector
plasmid
maintain
laboratori
g
gene
genbank
previous
describ
use
templat
pcr
amplifi
gene
use
sens
primer
antisens
primer
underlin
part
primer
reprens
bam
hi
xho
restrict
site
respect
amplifi
gene
region
point
link
primer
use
shown
supplement
figur
one
size
bp
pcr
product
clone
vector
plasmid
gene
sequenc
bgi
bgi
china
recombin
plasmid
transform
high
effici
chemic
compet
cell
ecoli
plyss
transgen
biotech
compani
beij
china
cell
cultur
lb
medium
contain
mgl
ampicillin
lb
medium
shaken
reach
isopropyldthiogalactosid
iptg
ad
final
concentr
mmoll
induc
express
cell
incub
h
harvest
centrifug
min
precipit
cell
resuspend
lysi
buffer
includ
mmoll
phosphat
buffer
salin
pb
ph
imidazol
mmoll
lysozym
gl
trypsin
inhibitor
gl
pepsin
inhibitor
gl
pmsf
gl
sonic
ice
cell
lysat
centrifug
min
supernat
collect
pour
ml
fast
flow
column
preequilibr
lysi
buffer
column
wash
imidazol
mmoll
pb
mmoll
ph
remov
nonspecif
bound
protein
elut
mmoll
imidazol
meanwhil
design
vector
control
protein
also
express
purifi
e
coli
condit
yield
protein
concentr
measur
use
pierc
protein
assay
kit
verifi
reactiv
purifi
protein
conduct
western
blot
use
purifi
protein
vector
control
protein
antigen
incub
antibefv
posit
antibodi
dilut
h
goat
anticattl
igg
conjug
peroxidas
dilut
abcam
usa
full
immunoblot
visual
enhanc
chemiluminesc
immunoassay
ecl
kit
thermo
fisher
scientif
inc
usa
peptid
librari
neb
new
england
biolab
usa
use
screen
bind
peptid
accord
manufactur
instruct
slight
modif
short
plate
coat
recombin
protein
concentr
biopan
carri
incub
phage
display
librari
phagesml
wash
away
unbound
phage
trisbuff
salin
tb
tween
bound
phage
elut
tb
titrat
describ
standard
protocol
subject
next
round
pan
second
third
fourth
round
pan
done
stringent
condit
use
less
amount
target
solut
recombin
protein
shorter
incub
time
h
h
h
round
respect
wash
higher
concentr
tween
respect
longer
time
min
min
min
inbetween
round
pan
titer
pan
phage
bind
buffer
refer
input
elut
buffer
refer
output
determin
ratio
output
input
analyz
assess
enrich
effici
four
round
pan
individu
clone
randomli
pick
amplifi
e
coli
strain
prepar
dna
individu
posit
phage
clone
amplifi
phage
singlestrand
dna
extract
purifi
use
phage
dna
rapid
extract
kit
spincolumn
signalway
biotechnolog
usa
dna
sequenc
sangon
sequenc
sangon
biotech
co
ltd
shanghai
china
use
giii
sequenc
primer
provid
peptid
librari
kit
amino
acid
sequenc
deduc
phage
display
peptid
dna
sequenc
expasi
translat
tool
http
webexpasyorgtransl
polypeptid
use
studi
synthesi
purifi
beij
scienc
technolog
co
ltd
irrelev
control
peptid
aemlel
acquir
anoth
screen
strategi
synthes
china
peptid
co
ltd
shanghai
china
phage
display
peptid
clone
differ
amino
acid
sequenc
subject
elisa
briefli
elisa
plate
coat
protein
concentr
dilut
moll
ph
overnight
meanwhil
purifi
vector
control
protein
coat
concentr
use
control
group
elisa
plate
block
block
buffer
bsa
h
room
temperatur
tenfold
serial
dilut
select
phage
ad
coat
plate
start
phage
first
well
plate
incub
h
room
temperatur
wash
time
tbst
tb
contain
bound
phage
detect
dilut
horseradish
peroxidas
hrp
conjug
antibodi
ge
healthcar
usa
block
buffer
final
peroxidas
activ
rapidli
detect
substrat
solut
tmb
upon
addit
sulfur
acid
stop
solut
absorb
reaction
determin
nm
elisa
micropl
reader
shanghai
utrao
medic
instrument
co
ltd
shanghai
china
cell
plate
cultur
plate
confluenc
amplifi
posit
phage
clone
concentr
pfuml
synthet
peptid
concentr
incub
ml
befv
h
respect
mixtur
viru
amplifi
posit
phage
variou
concentr
synthet
peptid
transfer
onto
cell
monolay
adsorpt
h
medium
replac
mainten
medium
contain
fb
ml
dmem
incub
h
treat
cell
supernat
collect
follow
three
cycl
altern
freez
thaw
store
use
vero
cell
cellswel
seed
plate
h
maintain
dulbecco
modifi
eagl
medium
dmem
invitrogen
usa
supplement
inactiv
fetal
bovin
serum
fb
gibco
usa
mix
antibiot
penicillin
iu
streptomycin
synthet
peptid
concentr
incub
ml
befv
h
transfer
onto
cell
monolay
h
incub
discard
supernat
cell
incub
normal
cultur
condit
h
monolay
spread
low
melt
agaros
format
cytopath
plaqu
visual
stain
cell
monolay
wv
neutral
red
solut
sigmaaldrich
usa
effect
peptid
befv
infect
evalu
count
plaqu
calcul
titer
pfuml
inhibitori
rate
total
rna
extract
treat
sampl
use
viral
rna
mini
kit
qiagen
valencia
ca
usa
elut
final
volum
revers
transcript
perform
use
primescript
rt
reagent
kit
takara
japan
accord
manufactur
protocol
sybr
greenbas
quantit
realtim
rtpcr
carri
use
premix
ex
taq
kit
accord
manufactur
protocol
takara
japan
total
volum
roch
lightcycl
real
time
pcr
system
roch
appli
scienc
germani
sequenc
primer
set
use
realtim
rtpcr
specif
primer
befv
n
gene
endogen
glyceraldehyd
dehydrogenas
gapdh
gene
list
tabl
realtim
rtpcr
carri
follow
min
follow
cycl
threshold
cycl
ct
valu
relat
rna
level
target
gene
normal
gapdh
express
rel
express
sampl
analys
method
treat
sampl
run
triplic
statist
analysi
perform
oneway
analysi
varianc
valu
consid
signific
p
figur
perform
use
prism
softwar
graphpad
softwar
inc
san
diego
ca
usa
gene
region
bp
addit
file
figur
amplifi
pcr
clone
vector
protein
express
ecoli
strain
mainli
exist
supernat
bacteri
lysat
indic
gene
effici
express
prokaryot
express
system
solubl
form
larg
amount
highli
express
protein
purifi
use
fast
flow
affin
media
result
sdspage
indic
obtain
highlypur
recombin
protein
expect
size
kda
meanwhil
expect
thioredoxin
protein
encod
empti
vector
alon
also
clearli
visibl
size
kda
fig
western
blot
perform
analyz
bioactiv
purifi
recombin
protein
result
indic
purif
recombin
protein
could
immunoreact
antibefv
antibodi
fig
therefor
data
indic
purifi
use
studi
biolog
activ
concentr
purifi
control
vector
protein
determin
absorb
nm
mgml
mgml
studi
phage
display
peptid
librari
use
screen
highaffin
ligand
could
select
bind
protein
follow
four
round
biopan
amount
input
phage
output
phage
determin
titrat
properti
phage
recoveri
effici
output
phagesinput
phage
round
calcul
shown
tabl
recoveri
effici
higher
four
round
pan
first
round
suggest
phage
specif
bound
protein
success
enrich
pan
round
total
phage
clone
randomli
select
amplifi
dna
select
posit
phage
clone
extract
sequenc
dna
sequenc
report
show
deduc
peptid
final
obtain
among
phage
present
tabl
align
peptid
reveal
probabl
put
bind
conserv
consensu
motif
phage
consensu
sequenc
yslrsdi
name
bear
yslr
similar
phage
clone
overlap
motif
sequenc
deriv
phage
hsirydf
name
order
test
bind
abil
select
phage
clone
independ
phage
clone
group
encod
differ
amino
acid
sequenc
select
detect
elisa
use
purifi
recombin
protein
target
shown
fig
absorb
obtain
phage
combin
target
protein
significantli
higher
control
vector
protein
among
bind
peptid
show
higher
bind
abil
protein
compar
clone
although
criterion
judg
posit
clone
suggest
clone
might
higher
affin
protein
clone
determin
whether
phage
display
peptid
potenti
inhibit
befv
infect
perform
virusblock
assay
cell
briefli
ml
befv
incub
individu
clone
titer
ml
display
peptid
irrelev
phage
respect
inocul
cell
meanwhil
nonphag
treat
befv
includ
control
incub
h
sybr
greenbas
realtim
rtpcr
perform
determin
rna
copi
befv
differ
phagetr
cell
result
show
peptid
significantli
exert
antivir
activ
phage
polypeptid
could
reduc
befv
rna
copi
number
time
decreas
time
compar
control
group
obvious
greatest
antivir
peptid
among
select
peptid
fig
investig
antivir
activ
select
polypeptid
firstli
synthes
peptid
born
phage
conduct
dosedepend
effect
synthet
peptid
inhibit
befv
replic
viru
plaqu
assay
indic
concentr
point
reduc
plaqu
assay
show
synthet
peptid
could
significantli
inhibit
format
cytopath
plaqu
concentr
group
nearli
abolish
plaqu
format
vero
cell
reduc
plaqu
result
serial
dilut
synthet
peptid
shown
fig
antivir
activ
synthet
peptid
determin
calcul
percentag
inhibitori
rate
compar
control
result
suggest
similar
trend
work
inhibit
befv
infect
turn
synthet
peptid
could
significantli
interfer
befv
format
cytopath
plaqu
p
fig
analyz
dose
depend
antivir
activ
synthet
peptid
alon
compar
synergist
effect
combin
use
befv
replic
shown
fig
result
real
time
rtpcr
show
synthet
peptid
alon
combin
use
could
significantli
inhibit
befv
rna
replic
p
exert
inhibit
befv
replic
dosedepend
manner
howev
effect
peptid
combin
similar
peptid
alon
p
fig
studi
molecular
mechan
viru
infect
basic
vital
approach
prevent
control
diseas
befv
infect
propos
attach
viru
host
cell
membran
via
interact
viral
envelop
g
protein
cell
surfac
receptor
consid
initi
step
befv
infect
protein
consid
main
protect
antigen
befv
react
sera
befv
current
molecular
serolog
diagnost
method
detect
befv
establish
base
protein
studi
aim
util
protein
target
protein
screen
ligand
preliminari
investig
role
bind
peptid
befv
infect
highli
effect
prokaryot
system
exemplifi
optim
choic
heterolog
protein
befv
protein
purifi
moder
form
solubl
fig
ensur
target
protein
nativ
configur
vitro
furthermor
specif
react
antibefv
antibodi
antigen
protein
fig
taken
togeth
glycoprotein
use
studi
biolog
activ
recent
year
use
purifi
protein
whole
viru
particl
target
phage
peptid
librari
screen
provid
ideal
approach
identifi
multifunct
peptid
studi
use
phagedisplay
heptapeptid
librari
identifi
protein
interactor
condit
select
strictli
limit
enrich
specif
phage
tabl
four
round
pan
deduc
peptid
amino
acid
sequenc
select
candid
phage
clone
exhibit
high
affin
protein
accord
elisa
fig
peptid
sequenc
show
partial
consensu
motif
tabl
indic
screen
process
success
meanwhil
partial
consensu
motif
possibl
typic
function
motif
complex
protein
would
promis
discov
ligand
glycoprotein
analyz
role
context
befv
infect
addit
report
befv
receptor
consensu
motif
may
mimic
discontinu
bind
site
receptor
agonistsantagonist
regul
biolog
function
receptor
phagedisplay
technolog
provid
effect
way
identifi
peptid
affin
specif
protein
diagnost
analysi
discoveri
mimic
antibodi
phage
bear
specif
affin
peptid
befv
protein
potenti
develop
phagemedi
diagnost
assay
befv
report
befv
protein
locat
ctermin
stalk
g
protein
one
target
virusneutr
antibodi
protein
linear
neutral
site
compris
two
minim
b
cell
epitop
potenti
signific
achiev
work
discoveri
mimic
antibodi
synthet
peptid
vitro
could
use
specif
antibodi
mimic
detect
befv
virusinfect
cell
peptid
ligand
target
specif
protein
surfac
obtain
phagedisplay
technolog
wide
use
therapeut
agent
interf
proteinprotein
interact
interestingli
phage
clone
exhibit
bind
affin
protein
antivir
activ
befv
fig
wherea
phage
high
affin
protein
effect
inhibit
replic
befv
mean
bind
affin
phage
necessarili
connect
antivir
activ
addit
possibl
explan
antivir
activ
protein
bind
phage
ligand
mediat
inhibitori
effect
befv
infect
competit
bind
receptor
bind
site
neutral
epitop
thu
inhibit
viru
attachmententri
order
exclud
effect
phage
protein
bind
antivir
activ
befv
synthes
peptid
vitro
conduct
reduc
plaqu
assay
vero
cell
significantli
form
cytopath
plaqu
befv
infect
result
show
synthet
peptid
could
significantli
inhibit
format
cytopath
plaqu
fig
inhibit
befv
replic
dose
depend
way
fig
altogeth
peptid
potenti
potent
antivir
molecul
worthi
develop
test
studi
provid
inexpens
way
discov
function
motif
befv
infect
use
phagedisplay
technolog
possibl
find
potenti
protein
mediat
interact
befv
host
summari
success
isol
protein
bind
peptid
phage
display
librari
antivir
effect
assay
show
peptid
dosedepend
effect
befv
infect
cellular
level
might
potenti
applic
diagnosi
treatment
befv
